GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Aker BioMarine ASA (OSL:AKBM) » Definitions » Shares Buyback Ratio %

Aker BioMarine ASA (OSL:AKBM) Shares Buyback Ratio % : -0.04 (As of May. 28, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aker BioMarine ASA Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Aker BioMarine ASA's current shares buyback ratio was -0.04%.


Aker BioMarine ASA Shares Buyback Ratio % Historical Data

The historical data trend for Aker BioMarine ASA's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aker BioMarine ASA Shares Buyback Ratio % Chart

Aker BioMarine ASA Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -26.84 - -0.06 -0.04

Aker BioMarine ASA Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -0.04 - - -

Aker BioMarine ASA Shares Buyback Ratio % Calculation

Aker BioMarine ASA's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2022 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Dec. 2022 )
=(87.6377 - 87.6728) / 87.6377
=-0.04%

Aker BioMarine ASA's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2023 ) - Shares Outstanding (EOP) (A: Mar. 2024 )) / Shares Outstanding (EOP) (A: Dec. 2023 )
=(87.6728 - 87.6728) / 87.6728
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aker BioMarine ASA Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Aker BioMarine ASA's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aker BioMarine ASA (OSL:AKBM) Business Description

Traded in Other Exchanges
Address
Oksenoyveien 10, P.O. Box 496, Lysaker, NOR, NO-1327
Aker BioMarine ASA is a supplier of krill-derived products, with a fully owned supply chain. The operations of the company span from harvesting krill in Antarctica with vessels owned by the company including distribution worldwide from Uruguay, and further processing of the krill into oil products in the United States. The segments of the company include 1) The Ingredients segment involves offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products. 2) The Brands segment focuses on human consumer goods, with Lang Pharma Nutrition (Lang) and Epion as its two main components. Lang produces and distributes private-label vitamins and supplements to retailers in the U.S. market and Epion is Aker BioMarine's consumer brand company.

Aker BioMarine ASA (OSL:AKBM) Headlines

No Headlines